A retrospective study investigating the frequency of postoperative bleeding complications following invasive dental procedures on patients using warfarin has found few episodes (Oral Surgery, Oral ...
Phase II monotherapy study of YM155, a novel survivin suppressant, administered by 168-hour continuous infusion in previously treated hormone refractory prostate cancer (HRPC) No significant financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results